These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19047104)

  • 1. Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.
    Singh RP; Raina K; Sharma G; Agarwal R
    Clin Cancer Res; 2008 Dec; 14(23):7773-80. PubMed ID: 19047104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Rajamanickam S; Singh RP; Deep G; Chittezhath M; Agarwal R
    Cancer Res; 2008 Aug; 68(16):6822-30. PubMed ID: 18701508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of silibinin on the growth and progression of primary lung tumors in mice.
    Singh RP; Deep G; Chittezhath M; Kaur M; Dwyer-Nield LD; Malkinson AM; Agarwal R
    J Natl Cancer Inst; 2006 Jun; 98(12):846-55. PubMed ID: 16788158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
    Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3.
    Tyagi A; Singh RP; Ramasamy K; Raina K; Redente EF; Dwyer-Nield LD; Radcliffe RA; Malkinson AM; Agarwal R
    Cancer Prev Res (Phila); 2009 Jan; 2(1):74-83. PubMed ID: 19139021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
    Singh RP; Gu M; Agarwal R
    Cancer Res; 2008 Mar; 68(6):2043-50. PubMed ID: 18339887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: comparison with silymarin and silibinin.
    Deep G; Raina K; Singh RP; Oberlies NH; Kroll DJ; Agarwal R
    Int J Cancer; 2008 Dec; 123(12):2750-8. PubMed ID: 18798272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.
    Singh RP; Raina K; Deep G; Chan D; Agarwal R
    Clin Cancer Res; 2009 Jan; 15(2):613-21. PubMed ID: 19147767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
    Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
    Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study.
    Raina K; Serkova NJ; Agarwal R
    Cancer Res; 2009 May; 69(9):3731-5. PubMed ID: 19366793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.
    Gupta S; Adhami VM; Subbarayan M; MacLennan GT; Lewin JS; Hafeli UO; Fu P; Mukhtar H
    Cancer Res; 2004 May; 64(9):3334-43. PubMed ID: 15126378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
    Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
    Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
    Singh RP; Deep G; Blouin MJ; Pollak MN; Agarwal R
    Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.
    Wu KJ; Zeng J; Zhu GD; Zhang LL; Zhang D; Li L; Fan JH; Wang XY; He DL
    Acta Pharmacol Sin; 2009 Aug; 30(8):1162-8. PubMed ID: 19578386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive efficacy of inositol hexaphosphate against prostate tumor growth and progression in TRAMP mice.
    Raina K; Rajamanickam S; Singh RP; Agarwal R
    Clin Cancer Res; 2008 May; 14(10):3177-84. PubMed ID: 18483386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model.
    Shukla S; MacLennan GT; Fu P; Gupta S
    Pharm Res; 2012 Jun; 29(6):1506-17. PubMed ID: 22139534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
    Singh RP; Tyagi A; Sharma G; Mohan S; Agarwal R
    Clin Cancer Res; 2008 Jan; 14(1):300-8. PubMed ID: 18172282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
    Wu K; Zeng J; Li L; Fan J; Zhang D; Xue Y; Zhu G; Yang L; Wang X; He D
    Oncol Rep; 2010 Jun; 23(6):1545-52. PubMed ID: 20428808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.